Biomarker evaluation in young onset dementia from diverse populations (beyondd)
Ended Project Grant Awarded Last action
- Award ID
- R56AG075744
- Recipient
-
The Regents Of The University Of California. San Francisco UEI KMH5K9V7S518
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,130,456
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- San Francisco, CA 94143, USA
Award details come from USAspending.gov.
Description
- Abstract
- / project summary early onset dementia (EOD) is devastating because IT affects individuals at a time of life when they have peak personal and professional responsibilities and are actively contributing to society. Previous work has identified alzheimer's disease (ad) and frontotemporal lobar degeneration (ftld) as the most common causes of EOD. Despite this, most studies of EOD primarily have recruited non-latinx whites (NLW). Black and latinx adults bear a disparate and disproportionate burden of biological and sociocultural vulnerabilities that confer increased adrd risk in older persons, but the etiologies of dementia in younger members of these diverse populations (DPS) are not well understood. Dedicated and well-resourced efforts specifically tailored to study EOD in DPS, including identification of unique risk and resilience factors, are urgently needed. Plasma biomarkers of amyloid, TAU and neurodegeneration and remotely collected automated clinical and cognitive assessments could greatly reduce barriers to characterization of EOD in DPS, but most studies evaluating these technologies have been conducted in older NLW. The biomarker evaluation in young onset dementia from diverse populations (beyondd) longitudinal study will address these gaps in knowledge. This five-year longitudinal study will implement a scalable, intensive, and culturally-informed community-engaged research approach to remotely enroll 2,000 adults (
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $6,065,228 | |
| Original award | $6,065,228 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Regents Of The University Of Michigan | $17,644 | |
| Regents Of The University Of Michigan | $77,400 | |
| Georgetown University | $93,600 | |
| University Of Puerto Rico Medical Sciences Campus | $149,000 | |
| The University Of Texas Health Science Center At San Antonio | $94,500 | |
| Mayo Clinic | $178,197 | |
| Regents Of The University Of Michigan | $50,887 | |
| Quest Diagnostics Incorporated | $131,200 | |
| Northern California Institute For Research And Education, Inc. | $833,084 | |
| Icahn School Of Medicine At Mount Sinai | $1,427,202 | |
| Research Foundation Of The City University Of New York | $129,604 |
Show all 11
Quick answers
Who received award R56AG075744?
R56AG075744 was awarded to The Regents Of The University Of California. San Francisco by National Institute on Aging (National Institutes of Health) on September 15, 2022.
How much is award R56AG075744 worth?
$12,130,456 has been obligated on R56AG075744.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award